Difficulty: Medium
Average Score: 67%
Practice
The drug can be used to treat nephrogenic diabetes insipidus:
Correct answer
A
Rationale
In the treatment of nephrogenic diabetes insipidus (NDI), the correct drug is Hydrochlorothiazide (HydroDiuril). NDI is a condition where the kidneys are unable to concentrate urine properly, leading to excessive urination and thirst. Hydrochlorothiazide is a thiazide diuretic that works by increasing the excretion of water without electrolytes, thereby reducing urine volume and helping to alleviate the symptoms of NDI.
Amiloride (Midamor) is a potassium-sparing diuretic that doesn't directly address the underlying issue in NDI, which is the impaired response of the kidney to antidiuretic hormone (ADH). Therefore, it is not the preferred treatment for this condition.
Choosing both options (C) is incorrect because while Hydrochlorothiazide can be used to treat NDI, Amiloride is not the first-line treatment for this specific condition.
Understanding the pharmacological treatment of NDI is crucial for healthcare professionals, especially those working in fields like nephrology or endocrinology. It is important to know the mechanism of action of each drug and how it specifically targets the underlying pathology of NDI to provide effective patient care. By grasping these concepts, healthcare providers can make informed decisions regarding drug therapy and optimize patient outcomes.
Amiloride (Midamor) is a potassium-sparing diuretic that doesn't directly address the underlying issue in NDI, which is the impaired response of the kidney to antidiuretic hormone (ADH). Therefore, it is not the preferred treatment for this condition.
Choosing both options (C) is incorrect because while Hydrochlorothiazide can be used to treat NDI, Amiloride is not the first-line treatment for this specific condition.
Understanding the pharmacological treatment of NDI is crucial for healthcare professionals, especially those working in fields like nephrology or endocrinology. It is important to know the mechanism of action of each drug and how it specifically targets the underlying pathology of NDI to provide effective patient care. By grasping these concepts, healthcare providers can make informed decisions regarding drug therapy and optimize patient outcomes.